KINDLER JEFFREY B
SEC insider (Form 3/4/5 filer). CIK 0001174454. Director at PRECIGEN, INC. (PGEN) and 3 other issuers. 27 reported Form 4/5 transactions since Sep 2024; latest on Aug 26, 2026. Located in GERMANTOWN, MD.
Companies KINDLER JEFFREY B has filed insider reports for
- PRECIGEN, INC. (PGEN): Director
- Praxis Precision Medicines, Inc. (PRAX): Director
- Terns Pharmaceuticals, Inc. (TERN): Director
- PERRIGO Co plc (PRGO): Director
KINDLER JEFFREY B
CIK: 0001174454
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (27 total)
- Aug 26, 2026PGEN
PRECIGEN, INC.
SaleDirect185K shares at avg. $7.44$1.4M - Jun 10, 2026PRAX
Praxis Precision Medicines, Inc.
AwardDirect1.4K shares- - May 5, 2026TERN
Terns Pharmaceuticals, Inc.
DispositionDirectStock Option (Right to Buy)
28.5K shares- - May 5, 2026TERN
Terns Pharmaceuticals, Inc.
DispositionDirectStock Option (Right to Buy)
4.7K shares- - May 5, 2026TERN
Terns Pharmaceuticals, Inc.
DispositionDirectStock Option (Right to Buy)
10.7K shares- - May 5, 2026TERN
Terns Pharmaceuticals, Inc.
DispositionDirectStock Option (Right to Buy)
32K shares- - May 5, 2026TERN
Terns Pharmaceuticals, Inc.
DispositionDirectStock Option (Right to Buy)
32K shares- - May 5, 2026TERN
Terns Pharmaceuticals, Inc.
DispositionDirectStock Option (Right to Buy)
45K shares- - May 5, 2026TERN
Terns Pharmaceuticals, Inc.
DispositionDirectStock Option (Right to Buy)
22K shares- - May 5, 2026TERN
Terns Pharmaceuticals, Inc.
DispositionDirectStock Option (Right to Buy)
32K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 26, 2026 |  PGEN PRECIGEN, INC. | Sale | 185,000 | $7.44 | $1,376,400 | Direct |
| Jun 10, 2026 |  PRAX Praxis Precision Medicines, Inc. | Award | 1,371 | - | $0 | Direct |
| May 5, 2026 |  TERN Terns Pharmaceuticals, Inc. | Disposition Stock Option (Right to Buy) | 28,475 | - | - | Direct |
| May 5, 2026 | TERN Terns Pharmaceuticals, Inc. | Disposition Stock Option (Right to Buy) | 4,676 | - | - | Direct |
| May 5, 2026 | TERN Terns Pharmaceuticals, Inc. | Disposition Stock Option (Right to Buy) | 10,657 | - | - | Direct |
| May 5, 2026 | TERN Terns Pharmaceuticals, Inc. | Disposition Stock Option (Right to Buy) | 32,000 | - | - | Direct |
| May 5, 2026 | TERN Terns Pharmaceuticals, Inc. | Disposition Stock Option (Right to Buy) | 32,000 | - | - | Direct |
| May 5, 2026 | TERN Terns Pharmaceuticals, Inc. | Disposition Stock Option (Right to Buy) | 45,000 | - | - | Direct |
| May 5, 2026 | TERN Terns Pharmaceuticals, Inc. | Disposition Stock Option (Right to Buy) | 22,000 | - | - | Direct |
| May 5, 2026 | TERN Terns Pharmaceuticals, Inc. | Disposition Stock Option (Right to Buy) | 32,000 | - | - | Direct |
1-10 of 27 transactions